Gabrielle Bennett

With recent therapeutic advances, the treatment landscape for metastatic castration-resistant prostate cancer is changing rapidly.

Nanoparticles acting as cancer drug delivery vehicles show promise in eliminating tumors.

Controversy swirls around the naming protocol for biosimilars among drug manufacturers and the FDA.

Mergers and acquisitions among pharmacy benefit managers may help limit medication cost hikes.

Transition of provider-administered drugs from the physician office to the hospital remains a key cost driver of pharmacy spend.

There are several ongoing global phase 3 clinical trials for biosimilar adalimumab, which treats conditions such as rheumatoid arthritis, psoriatic arthritis, and Crohn's Disease.

Approximately 40% of the elderly and nearly 11% of the US population take 5 or more prescription drugs.

Specialty pharmacy automatic refill programs weigh improved adherence versus medication oversupply.

Specialty benefit design and management tools can ensure optimal patient care.

States have instituted multiple policies to control prescription drug costs, including limits on the number of reimbursable prescriptions.

Concerns persist that automatic prescription refill programs increase medication oversupply.

Efforts to limit access to medications could have a negative impact on overall expenditures.

Electronic prescribing systems can influence prescriber behavior and may result in lower prescription medication costs.

The annual cost to the Medicare system for IPF is estimated to be $1 billion annually.

Specialty benefit design and management tools employed by pharmacy benefit managers can help control specialty drug spending and ensure optimal patient care.

Cancer treatment advances are now moving to the clinic with great promise, just as precision therapy and immunotherapy are transforming cancer therapy itself.

Prohibitive cost to Medicaid for hepatitis C medications and high prices of generic and off-patent drugs evaluated.

Coffee appears to confer a number of protective effects against liver disease.